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Abstract
Acetyl-CoA carboxylase (ACC) catalyzes the first committed step in the synthesis of long-chain fatty acids.
The crystal structure of the Escherichia coli carboxyltransferase component of ACC revealed an a2b2
subunit composition with two active sites and, most importantly, a unique zinc domain in each ab pair that
is absent in the eukaryotic enzyme. We show here that carboxyltransferase binds DNA. Half-maximal
saturation of different single-stranded or double-stranded DNA constructs is seen at 0.5–1.0 mM, and
binding is cooperative and nonspecific. The substrates (malonyl-CoA and biocytin) inhibit DNA:carboxyltransferase complex formation. More significantly, single-stranded DNA, double-stranded DNA, and
heparin inhibit the reaction catalyzed by carboxyltransferase, with single-stranded DNA and heparin acting
as competitive inhibitors. However, double-inhibition experiments revealed that both DNA and heparin can
bind the enzyme in the presence of a bisubstrate analog (BiSA), and the binding of BiSA has a very weak
synergistic effect on the binding of the second inhibitor (DNA or heparin) and vice versa. In contrast, DNA
and heparin can also bind to the enzyme simultaneously, but the binding of either molecule has a strong
synergistic effect on binding of the other. An important mechanistic implication of these observations is that
the dual active sites of ACC are functionally connected.
Keywords: acetyl-CoA carboxylase; carboxyltransferase; biotin; zinc finger; DNA binding

Acetyl-CoA carboxylase is a multifunctional biotindependent enzyme that catalyzes the first committed
and regulated step in fatty acid biosynthesis in bacteria
via a two-step reaction (Scheme 1).
Biotin carboxylase catalyzes the first half-reaction,
which is an ATP-dependent carboxylation of biotin to form
carboxybiotin. The second half-reaction is catalyzed by
carboxyltransferase, which transfers the carboxyl group
from carboxybiotin to acetyl-CoA to generate malonylCoA. Biotin is covalently attached to the biotin carboxyl
Reprint requests to: Grover L. Waldrop, Department of Biological
Sciences, Room 206 Life Sciences Building, Louisiana State University, Baton Rouge, LA 70803, USA; e-mail: gwaldro@lsu.edu; fax:
(225) 578-7258.
Abbreviations: ACC, acetyl-CoA carboxylase; BCCP, biotin carboxyl carrier protein; IHF, integration host factor; BiSA, bisubstrate
analog; EMSA, electrophoretic mobility shift assay.
Article and publication are at http://www.proteinscience.org/cgi/
doi/10.1110/ps.073186408.
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carrier protein (BCCP), and this complex is designated
‘‘Enzyme-biotin’’ in Scheme 1. In bacteria, the BCCP and
the two enzymatic functions are encoded as three separate
proteins (Cronan and Waldrop 2002). However, in eukaryotes, a single polypeptide chain comprises all three functional domains (Tanabe et al. 1975).
The recent crystal structures (Fig. 1) of carboxyltransferase from Escherichia coli and Staphylococcus aureus
revealed a unique domain absent from eukaryotic homologs
(Bilder et al. 2006). The structure confirmed the a2b2
subunit composition suggested by Lane and colleagues
(Guchhait et al. 1974) and showed that the enzyme belongs
to the crotonase superfamily (Gerlt and Babbitt 2001). The
enzyme contains two active sites that lie at the interface
of each of the ab pairs (Fig. 1). The overall fold, not
surprisingly, is similar to that of the carboxyltransferase
domain from yeast (Zhang et al. 2003) and Streptomyces
coelicolor (Diacovich et al. 2004). However, when the gene
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Scheme 1

for the b-subunit of E. coli carboxyltransferase was cloned
and sequenced 20 years ago, the authors noted the tandem
C-X-X-C sequences separated by 15 residues located at the
amino terminus and hypothesized that the protein may bind
a metal ion (Bognar et al. 1987). The crystal structures of
carboxyltransferase from S. aureus and E. coli, along with
X-ray fluorescence studies, have, indeed, confirmed this
prediction. The metal atom is zinc, and it forms part of a
zinc motif that is unique to bacterial carboxyltransferase
(Fig. 1). A space-filling representation reveals that the Zn
domain forms part of a saddle-like structure (Fig. 2), and an
electrostatic surface potential rendering shows that the
inner face of the zinc finger domain has an electropositive
surface potential, while most of the protein has an electronegative surface potential.
Given that Zn domains are commonly associated with
DNA binding, and noting the favorable electrostatic
potential, the aim of this study was to determine the
ability of E. coli carboxyltransferase to bind DNA and
characterize the effect of DNA binding on the enzymatic
activity of carboxyltransferase. The results show that DNA,
indeed, inhibits enzymatic activity; notably, the mode of
binding reveals communication between the dual active sites
of the functional protomers.
Results
DNA inhibits carboxyltransferase activity
The zinc domain in bacterial carboxyltransferase belongs
to the zinc ribbon class of zinc fingers (Krishna et al.
2003). Proteins that contain this type of zinc finger are

Figure 1. Ribbon drawing of carboxyltransferase from S. aureus. (Purple)
The a-chain; (gold) the b-chain. (Blue sphere in the b-chain) The zinc atom.

frequently associated with DNA metabolism, such as the
transcription factors TFIIS (Qian et al. 1993), TFIIB (Zhu
et al. 1996), TFIIE (Okuda et al. 2004), several subunits
from RNA polymerase II (Cramer et al. 2003), human
ssDNA-binding protein RPA (Cochkareva et al. 2002),
and bacteriophage T4 and T7 primases (Cha and Alberts
1986; Mendelman and Richardson 1991). Isolated zinc
fingers like that in carboxyltransferase do not bind DNA
tightly and recognize only three nucleotides (Wolfe et al.
2000). For example, T7 and T4 primases, recognize a
preferred 3-nt sequence (Mendelman et al. 1999). Since
carboxyltransferase contained an isolated zinc finger, it
was assumed initially that DNA binding would be nonspecific. Therefore, to assess the ability of DNA to inhibit
carboxyltransferase activity, random DNA sequences of
varying lengths were examined. As shown in Figure 3,
increasing concentrations of a 4-nt sequence composed of
each of the four nucleotides, and a 30-nt PCR primer along
with its complementary strand (i.e., the 30-bp DNA fragment) (Table 1) did, indeed, attenuate enzymatic activity
comparably. It was not possible to test larger DNA fragments because the increased viscosity of the assay solution
became prohibitive. However, viscosity or ionic strength is
unlikely to account for the decrease in enzymatic activity
due to the 4-nt and 30-nt DNA fragments since they inhibit
to the same extent but would confer different viscosities
and ionic strengths on the solutions. It is important to note
that a thymidine dimer did not inhibit activity (data not
shown), and that nucleotides have been previously reported
not to affect activity (Polakis et al. 1973), suggesting that
carboxyltransferase likely binds at least 3 nt. While the site
of DNA binding has not been rigorously determined, we
surmise that it includes the zinc finger given the overwhelming precedent for zinc fingers binding DNA.
A single-stranded DNA substrate (30 nt upstream
sequence) (Table 1) was used to examine the type of
inhibition with respect to the substrates malonyl-CoA
and biocytin.1 The 30-nt ssDNA exhibited competitive
inhibition with respect to both malonyl-CoA and biocytin
1
The catalytic activity of carboxyltransferase from E. coli is often
measured in the reverse, or nonphysiological, direction with a facile
spectrophotometric continuous assay. The assay links the production
of acetyl-CoA to the reduction of NAD+ by the coupled reactions of
citrate synthase and malate dehydrogenase (Blanchard and Waldrop
1998). Biocytin is preferred over biotin because biocytin produces a
maximal velocity three orders of magnitude greater than does biotin
(Blanchard and Waldrop 1998). Biocytin is a biotin molecule with a
lysine appended to the carboxyl group of the valeric acid side chain
via an amide linkage at the e-amino group.
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Figure 2. Electrostatic surface potentials of the heterotetramer of carboxyltransferase. (Blue) A net positive charge; (red) a net negative charge. The surface potentials were generated with the program Grasp (Nicholls et al. 1991).

(Fig. 4A,B). Fitting the data to Equation 1 gave inhibition
constants (Ki) of 85 6 10 mM with respect to malonyl-CoA
and 34.2 6 4.0 mM with respect to biocytin. The DNA
mimic heparin was also found to inhibit enzymatic activity,
and like DNA, exhibited competitive inhibition with respect
to both substrates (Fig. 4C,D). The inhibition constants (Ki)
for heparin are 1.2 6 0.1 mM with respect to malonyl-CoA
and 2.2 6 0.3 mM with respect to biocytin.
These inhibition data are consistent with electrophoretic
mobility shift assays (EMSA), which show that increasing
concentrations of malonyl-CoA inhibit formation of the
carboxyltransferase–DNA complex (Fig. 5A). Moreover, a
bisubstrate analog (BiSA) inhibitor of carboxyltransferase,
in which coenzyme A is covalently attached to carboxybiotin (Levert and Waldrop 2002), was an even more
efficient inhibitor of the enzyme–DNA complex (Fig.
5B). The substrate biocytin also inhibited formation of
the carboxyltransferase–DNA complex, but only at very
high concentrations (data not shown); because carboxyltransferase has an ordered addition of substrates with
malonyl-CoA binding first (Blanchard and Waldrop 1998;
Levert and Waldrop 2002), and given that biocytin exhibits
substrate inhibition, at high concentrations biocytin binds in
the malonyl-CoA-binding site and inhibits DNA binding.
The competitive inhibition patterns indicate that DNA
and heparin bind to the same enzyme form as the substrates
malonyl-CoA and biocytin (namely, carboxyltransferase
without substrates bound). In order to characterize the
topological relationship between the DNA binding site
and the active site (e.g., do the two sites overlap?), multiple
inhibition studies were performed. Multiple inhibition experiments are carried out by measuring the initial velocity at increasing concentrations of one inhibitor while the
second inhibitor is held constant. The substrate concen36
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trations are held constant at subsaturating levels. The initial
velocities are measured again at higher levels of the second
inhibitor and then plotted as 1/velocity versus the concentration of the first inhibitor (sometimes referred to as a
Yonetani-Theorell plot) (Yonetani and Theorell 1964). It is
important to keep in mind that unlike the inhibition studies
in Figure 4, A and B, where the substrate concentrations are
extrapolated to infinity, the substrate concentrations in
multiple inhibition experiments are held constant at subsaturating levels, which allows both inhibitors to bind to the
enzyme. The first inhibitor for these studies was the
bisubstrate analog (BiSA) used above for the EMSA assays.
Since the substrate concentrations are held constant at
subsaturating levels, BiSA could theoretically bind to an
active site that already has DNA bound to it or to the other
active site, which does not have DNA bound. Double
inhibition of carboxyltransferase by either DNA or heparin
at different fixed levels of BiSA (Fig. 6A,B) yielded
intersecting patterns, which indicate that the two inhibitors
can bind to the enzyme simultaneously. Thus, the binding
site for DNA and the active site of the enzyme are
topologically distinct, which suggests DNA binding at
one ab dimer, while BiSA binds to the other ab dimer.
This scenario is supported by fitting the data to Equation 2;
b values of 0.50 and 0.85 were found for the DNA–BiSA
inhibition and the heparin–BiSA inhibition, respectively.
The b value is an indication of the interaction of the two
inhibitors. Values of b >1 indicate that the binding of the
two inhibitors interfere with one another, while a value of
1 indicates no interaction between the inhibitors. A b value
<1 indicates synergism in the binding of the inhibitors.
Thus, the binding of either DNA or heparin shows very
weak synergism with the binding of BiSA and vice versa.
Surprisingly, double-inhibition analysis with DNA and
heparin also resulted in an intersecting pattern (Fig. 6C),
indicating that DNA and heparin can bind to the enzyme
simultaneously. However, the b value of 0.02 reflects a
strong synergistic relationship in the binding of the two
inhibitors. Given the presence of two Zn domains per

Figure 3. Dose-response curve for carboxyltransferase with both ssDNA
and dsDNA. Initial velocity was measured at increasing amounts of DNA
(4-nt ssDNA, 30-nt ssDNA, and 30-nt dsDNA) (Table 1). Malonyl-CoA
was held constant at 0.1 mM, while biocytin was held constant at 5.0 mM.

DNA inhibits carboxyltransferase

Table 1. Primers used for amplification of substrate DNA or for enzyme inhibition assays
Primer name

Amplicon locus

Upstream primer
sequence (59 to 39)

Downstream primer sequence
(59 to 39) or complement for annealing

accD #1
accD #2
accA #1
accA #2
accB/C
Control
ivt accA
ivt accD
4 nt
30 nt

161 to +13
288 to +11
6729 to 6437
495 to +4
292 to +7
28 to +251
213 to +960
96 to +914
N/A
N/A

AAATAAAAAGTAACTCCGCGGTTCG
TTTCTTCGGTACAATCCCGATGGT
CAAAGTCTGGCGCAAAACCGCTGC
GTTGCCGCGCGGGTTATGGTCACC
TTGCTACGAAATCGTTATAATGTG
GCCTGGCATTTGCTGAATTTGACGA
GCCGGGAATTCTGACCAGCTTTTAAACCG
GCCGGCTCGAGTGTGCAACATTCATGGTCT
TACG
TGACCATGATTACGCCAAGCTATTTAGGTG

TCAATCCAGCTCATTAGGGACCTTT
AATCCAGCTCATTAGGGACCTTTC
CTTCAAAATCCAGCACGCGATCCA
CTCATAGTATTCCTGTATTAGTCA
ATATCCATGAGTGGGTTCCGTACT
TCGTCAAATTCAGCAAATGCCAGGC
CCGGCGGATCCTTACGCGTAACCGTAGCTC
CCGGCGGATCCTCAGGCCTCAGGTTCCTGA
N/A
CACCTAAATAGCTTGGCGTAATCATGGTCA

Amplicon locus is given relative to the A of the start codon (ATG). Primers accD #1 and #2 were used to amplify a 175-bp and a 300-bp region of the E. coli
chromosome predicted to contain the promoter for accD (carboxyltransferase b gene). accA #1 and #2 were used to amplify a 292-bp and a 500-bp region
of the E. coli chromosome predicted to contain the promoter for accA (carboxyltransferase a gene). accB/C were used to amplify a 300-bp region of the
E. coli chromosome reported to contain the promoter for the accB and accC (genes for biotin carboxylase and biotin carboxyl carrier protein, respectively).
‘‘Control’’ was used to amplify a 280-bp region starting at the 59 end of the coding sequence within accD. ivt accA was used to amplify accA from the 213
position (10) to the end of the gene to generate template for in vitro transcription. ivt accD was used to amplify accD from the 96 position (10) to the end
of the gene and was used to generate in vitro transcription template. The 4-nt and both 30-nt primers were used to study the inhibitory affects of DNA on
catalysis by carboxyltransferase.

protomer, the simplest explanation is that binding at one
site enhances binding at the other.
DNA binding by carboxyltransferase
Since the multiple inhibition studies showed that DNA and
the DNA mimic heparin exhibit synergistic binding to
carboxyltransferase, DNA binding was characterized using
EMSA. As shown in Figure 7A, carboxyltransferase binds
30-nt ssDNA in preference to duplex as evidenced by the
disappearance of free ssDNA and the concomitant formation
of a complex that fails to migrate from the well of the gel.
When carboxyltransferase was incubated with only ssDNA
and the region on the gel from the slowest migrating
complex to the free nucleic acid was considered as the
protein–DNA complex, quantification of the data shows that
ssDNA binds to carboxyltransferase in a cooperative fashion
(Fig. 7B), with a half-maximal saturation of 480 6 18 nM
(Table 2). That complexes formed at higher carboxyltransferase concentrations fail to migrate from the well suggests
the formation of aggregates, consistent with the presence of
two zinc domains, the presumed sites of DNA binding.
Since the four components (i.e., biotin carboxylase,
BCCP, and the a and b subunits of carboxyltransferase)
of the E. coli acetyl-CoA carboxylase are likely produced in
a defined, stoichiometric ratio, and since expression of the
genes has been reported to be directly correlated to cellular
growth rates (Li and Cronan 1993), we explored the
possibility that carboxyltransferase may contribute to regulation of any of the genes encoding the acetyl-CoA
carboxylase subunits.
Carboxyltransferase binds a 175-bp DNA containing the
accD promoter (i.e., the gene encoding the b-subunit) (Li

and Cronan 1993), as evidenced by the formation of a
complex that fails to migrate from the well of the gel
(Fig. 8A). As with the 30-nt ssDNA, binding was cooperative with a half-maximal saturation of 946 6 32 nM (Table
2). This confirms that cooperative binding was not unique
to ssDNA. In fact, carboxyltransferase bound cooperatively
to DNA corresponding to the promoter regions of the gene
coding for the a-subunit (accA), and the operon that
includes the genes for biotin carboxylase and the biotin
carboxyl carrier protein as well as a 280-bp DNA representing the accD-coding region. The comparable halfmaximal saturation for all the DNA sequences examined
(Table 2) suggests that carboxyltransferase binds DNA with
low affinity and nonspecifically.
While we cannot rule out that carboxyltransferase may
be recruited to specific DNA sites by association with other
factors, it is important to note that addition of biotin
carboxylase or the biotin carboxyl carrier protein (biotinylated and unbiotinylated) did not increase the affinity of
carboxyltransferase for duplex or single-stranded DNA,
suggesting that the other components of acetyl-CoA carboxylase do not confer high-affinity DNA binding (data not
shown). Moreover, while acyl-ACP has been reported to be a
feedback inhibitor of carboxyltransferase (Davis and Cronan
2001), we found that increasing amounts up to 100 mM had
no effect on formation of the DNA–carboxyltransferase
complex (data not shown). In addition, MfpA, a protein
from Mycobacterium tuberculosis that provides resistance to
fluoroquinolones by mimicking DNA and binding to DNA
gyrase (Hegde et al. 2005), also did not inhibit formation of
the carboxyltransferase–DNA complex (data not shown).
Lastly, considering the potential for carboxyltransferase
looping DNA and the presence of AT-rich sequences weakly
www.proteinscience.org
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resembling consensus binding sites for integration host
factor (IHF) (Freundlich et al. 1992; Hales et al. 1994,
1996), we assessed the ability of IHF to enhance carboxyltransferase–DNA complex formation. IHF did not increase
the affinity of carboxyltransferase for either of the promoter
regions of the genes for the a- and b-subunits (data not
shown). Taken together, the results indicate that carboxyltransferase exhibits nonspecific, cooperative DNA binding.
Discussion
DNA-binding enzymes
Few enzymes that catalyze a reaction in intermediary
metabolism also bind DNA or RNA. Examples include PutA
(proline utilization A) (Brown and Wood 1992); BirA or
biotin ligase, which attaches biotin to the biotin carboxyl
carrier protein (Beckett 2005); the plant cysteine protease
LeCp (Matarasso et al. 2005); Arg 5,6, which is involved
in arginine biosynthesis (Hall et al. 2004); Ilv5p, which
catalyzes a reaction in branched-chain amino acid biosynthesis (Bateman et al. 2002a); and iron regulatory protein 1
(IRP1), which binds mRNA and functions as aconitase
(Walden et al. 2006). These proteins all have dual functions;
they either act as enzymes or as nucleic acid binding
proteins, and, most importantly, these two functions can be
separated. For example, the DNA-binding domain of PutA

Figure 4. Inhibition of carboxyltransferase by (A, B) DNA and (C, D)
heparin. When malonyl-CoA was the variable substrate, biocytin was held
constant at 5.0 mM, and when biocytin was the variable substrate,
malonyl-CoA was held constant at 0.1 mM. The points are the reciprocal
of the experimental velocities, and the lines are derived from the best fit of
the data to Equation 1. The error on each velocity is <10%.
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Figure 5. Inhibition of the formation of DNA:carboxyltransferase complex by malonyl-CoA and BiSA. All reactions contained 50 fmol of 300-bp
carboxyltransferase b promoter DNA. (A) Reactions in lanes 2–10 have
800.0 nM carboxyltransferase; malonyl-CoA is titrated in reactions from
lanes 3–10 (from 10.0 mM to 10.0 mM). (B) Reactions in lanes 2–10 have
800.0 nM carboxyltransferase; BISA is titrated in reactions in lanes 3–10
(from 2.5 mM to 2.5 mM).

DNA inhibits carboxyltransferase

inhibition patterns indicate that saturating levels of either
substrate prevent DNA binding. This makes intuitive sense
for malonyl-CoA; the b-subunit contains the zinc domain,
the presumed DNA binding site, in close proximity to the
malonyl-CoA-binding site. Biocytin, however, binds to the
a-subunit. Given that DNA is a polymer, the competitive
inhibition pattern with respect to biocytin is likely due to a
steric effect, where the polymeric DNA blocks access to the
biocytin-binding site. Inhibition of carboxyltransferase by
DNA is consistent with EMSA data showing that malonylCoA as well as a bisubstrate analog prevent formation of the
DNA–protein complex. Thus, enzymatic activity and DNA
binding are not separable functions.
The cooperative binding of DNA to carboxyltransferase
is likely a manifestation of two separate physical phenomena. Carboxyltransferase has two zinc domains diametrically opposed, and DNA has multiple binding sites.
Accretion of carboxyltransferase mediated by protein–
protein interactions could account for the observed cooperativity. Second, the binding of DNA to one site on
carboxyltransferase could increase the affinity for DNA
binding to the second site. Significantly, evidence for
intersubunit communication is also seen in the multiple
inhibition experiments with DNA and heparin (Fig. 6)
where the b value, which reports on the degree of synergism in the binding of the two inhibitors, is well below

Figure 6. (A–C) Multiple inhibition patterns for DNA (ssDNA 30-nt
upstream sequence) (Table 1), heparin, and BiSA. The points are the
reciprocal of the experimental velocities, and the lines are derived from
the best fit of the data to Equation 2. Malonyl-CoA was held constant at
0.1 mM, while biocytin was held constant at 5.0 mM.

can be expressed and purified without the enzymatic domain,
and it still binds DNA (Gu et al. 2004). For Ilv5p, either the
DNA-binding domain or the enzymatic domain can be inactivated without affecting the activity of the other domain
(Bateman et al. 2002b). What distinguishes carboxyltransferase from these enzymes is that catalysis and DNA binding
are inextricably linked and that DNA binding is cooperative.
The mode of DNA binding suggests communication
between the dual active sites
DNA and heparin are competitive inhibitors with respect to
both substrates malonyl-CoA and biocytin. The competitive

Figure 7. Electrophoretic analysis of DNA titrated with carboxyltransferase. (A, lane 1) ssDNA (50.0 fmol). The remaining reactions contained a
50-fmol ssDNA with one-half molar ratio complementary strand, annealed
by cooling over 3 h from 95°C to 0°C. Reactions in lanes 3–15 contain 0.1,
0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, and 2.4 mM carboxyltransferase. (B) Binding isotherm for carboxyltransferase binding to
ssDNA in the absence of dsDNA (30-nt upstream primer sequence) (Table
1). The line represents the best fit of the data to Equation 3.
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1 (0.02). This synergistic binding of DNA to carboxyltransferase could certainly contribute to the sigmoidal curve
observed for DNA binding. Taken together, our data
suggest functional communication between the dual active
sites of carboxyltransferase. Synergistic substrate binding
to carboxyltransferase in vivo would promote rapid initiation of fatty acid biosynthesis under favorable conditions.

be bound to DNA. Even if the Kd were 10-fold higher in vivo
(given the higher intracellular salt concentrations), 90% of
the enzyme would still be bound to DNA, again assuming
that only 10% of the genomic DNA is available for binding.
What might be the consequences of a significant fraction
of carboxyltransferase being bound to DNA? The observation that both substrates inhibit DNA binding is very
important when considering how carboxyltransferase could
function as a critical enzyme for membrane biogenesis. It is
tempting to speculate that during the stationary phase of
E. coli growth, where nutrients are limited, carboxyltransferase functions as a nucleoid-associated protein (Drlica
and Rouvieı̀re-Yaniv 1987) to compact and protect the
chromosome from damage. During the growth phase when
nutrients are abundant, the levels of substrates, most
notably acetyl-CoA, increase dramatically and compete
with DNA for binding to carboxyltansferase, and the
enzyme functions to synthesize fatty acids for cell membrane assembly. During stationary phase, when carboxyltransferase activity is low, association with nucleic acids
(ssDNA and dsDNA) may also prevent futile activity and/or
the sequestration of cellular metabolites.

Does carboxyltransferase bind DNA in vivo?

Materials and Methods

The physical parameters derived from this work can be
used to predict whether carboxyltransferase might bind
DNA in vivo. A 3-nt binding site is assumed, which is
consistent with other zinc finger-binding sites (Wolfe et al.
2000). However, based on the dimensions of carboxyltransferase, a single molecule of enzyme would occlude
;30 bp, which would result in 1.5 3 105 or 0.75 mM
potential binding sites for carboxyltransferase. The intracellular concentration of carboxyltransferase is ;500 nM
(Guchhait et al. 1974). Using 0.8 mM as the binding
constant of DNA to carboxyltransferase, the fraction of
carboxyltransferase bound to DNA intracellularly can be
calculated with the following equation (Segel 1975):

Restriction enzymes, dNTPs, and T4 DNA ligase were purchased
from New England Biolabs. Pfu Turbo DNA polymerase was from
Stratagene. Primers for PCR and oligonucleotides used to generate

Table 2. Half maximal values for carboxyltransferase binding
to substrate DNA molecules
DNA

EC50 (nM)

175-bp carboxyltransferase b promoter
300-bp carboxyltransferase b promoter
292-bp carboxyltransferase a promoter
500-bp carboxyltransferase a promoter
300-bp BCCP/BC promoter
280-bp accD coding region sequence
30-nt PCR primer

946
673
751
821
794
783
480

(632)
(636)
(625)
(628)
(647)
(637)
(618)

Hill coefficient
1.7
1.8
2.1
2.0
1.5
1.5
2.6

(60.2)
(60.2)
(60.2)
(60.2)
(60.2)
(60.2)
(60.2)

EC50 values and Hill coefficients for DNA substrates were determined by
quantifying EMSA gels and fitting data to Equation 1.

½ES = ð1=2Þðð½Et + ½St + KsÞ  ðð½Et + ½St + KsÞ2
 4½Et½StÞ1=2 Þ
where Et is the concentration of carboxyltransferase, St is the
concentration of DNA-binding sites, and Ks is the dissociation constant for DNA binding to carboxyltransferase.
Assuming that the entire E. coli genome is accessible to
carboxyltransferase, the calculation suggests that all of the
enzyme would be bound to DNA in vivo. However, most of
the genomic DNA in E. coli is compacted by proteins
(Minsky 2004) and would be inaccessible to carboxyltransferase, yet recalculation assuming only 10% of the genomic
DNA available for binding to carboxyltransferase also
suggests that all of the carboxyltransferase in E. coli would
40
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Figure 8. Electrophoretic analysis of 175-bp dsDNA from promoter region
of accD (carboxyltransferase b-subunit) titrated with carboxyltransferase.
(A) Reactions contain 50.0 fmol of DNA. Reactions in lanes 2–15 contain
0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.4, and 2.6 mM
carboxyltransferase. (B) Binding isotherm for carboxyltransferase binding to
175-bp dsDNA. The line represents the best fit of the data to Equation 3.

DNA inhibits carboxyltransferase

dsDNA and ssDNA used as inhibitors were obtained from MWG
BioTech. Heparin, coupling enzymes, and NAD were from Sigma/
Aldrich. The bisubstrate analog (BiSA) inhibitor of carboxyltransferase was synthesized according to the method of Levert and
Waldrop (2002). [g-32P]ATP was from PerkinElmer. QIAquick
Gel Extraction Kit and DNeasy Tissue Kit were from QIAGEN,
Inc. IHF was obtained as described by Grove et al. (1996). MfpA
was kindly provided by John Blanchard, Albert Einstein College
of Medicine, New York.

Purification and enzymatic assay of carboxyltransferase
Carboxyltransferase was purified from E. coli transformed with
an overexpression plasmid containing a mini-operon with genes
for the a- and b-subunits of the enzyme (Blanchard and Waldrop
1998).
Carboxyltransferase activity was measured in the reverse
direction with a spectrophotometric assay in which the production
of acetyl-CoA was coupled to the combined citrate synthasemalate dehydrogenase reaction requiring NAD+ reduction (Blanchard and Waldrop 1998). NADH formation was followed spectrophotometrically at 340 nm using a Uvikon 810 (Kontron
Instruments) spectrophotometer interfaced to a PC equipped with
a data acquisition program. Since the crystal structure showed that
carboxyltransferase contains two active sites, the initial velocities
were calculated per active site using a molecular weight of 68.5
kDa for each ab dimer (i.e., active site). Control experiments
showed that neither DNA nor heparin at the highest concentration
used in Figure 4 inhibited the coupling enzymes citrate synthase or
malate dehydrogenase.

nucleic acid was considered as complex. The percent complex was
calculated as complex intensity divided by the total intensity (or total
nucleic acid) in a given lane. Binding assays were carried out in
duplicate. Binding isotherms are from representative EMSAs, with
<17.5% variation between experiments.
Inhibitors of DNA binding by carboxyltransferase were analyzed by measuring percent complex versus inhibitor concentration. A competition assay was carried out similar to the binding
assay for affinity determination (above), except the carboxyltransferase was held constant and the inhibitor concentration varied.
The order of addition for each of the regents in the competition
assay is as follows: buffer, carboxyltransferase, inhibitor molecule(s), and labeled DNA.

Data analysis
Competitive inhibition data were fitted to Equation 1, using the
programs of Cleland (1979). In Equation 1, v is the initial velocity,
Vm is the maximal velocity, A is the substrate concentration, I is
the concentration of inhibitor, Km is the Michaelis constant, Ki is
the inhibition constant. Data for multiple inhibitions were fitted
to Equation 2, where v is the initial velocity, I and J are the
concentrations of the two inhibitors, v0 is the velocity in the
absence of inhibitors, Ki and Kj are the apparent dissociation
constants for the two inhibitors, and b is a measure of the degree
of interaction of the two inhibitors (Cleland 1990). The binding
isotherms for carboxyltransferase binding to DNA were analyzed
by fitting the data to Equation 3 to calculate the concentration of
protein resulting in half-maximal saturation (EC50). In Equation 3,
Y equals the fractional complex, while min is the minimum value
of Y and max is the maximum value of Y. x is the concentration of
carboxyltransferase, and n is the Hill coefficient.

DNA substrates
The promoter regions for the a (292-bp and 500-bp fragments)
and b (175-bp and 300-bp fragments) genes of carboxyltransferase, the promoter region for the biotin carboxylase/biotin carboxyl
carrier protein (300-bp fragment), and a 280-bp fragment encompassing part of the accD coding region were PCR-amplified using
the primers listed in Table 1. E. coli (JM109; New England
Biolabs) chromosomal DNA isolated via DNeasy Tissue kit was
used as the template. The PCR products were electrophoresed, and
their concentration was assessed by densitometry by comparing
sample intensity to that of similar-sized molecular weight standards. The PCR products were 59-end-labeled with T4 polynucleotide kinase and [g-32P]ATP and purified via QIAquick Gel
Extraction Kit, assuming 90% sample recovery.

Electrophoretic mobility shift assay (EMSA)
The reactions (total reaction volume of 10 mL) included 50 fmol
of DNA, with carboxyltransferase titrated from 0 to 2.6 mM. The
binding buffer was 20 mM Tris-HCl (pH 8), 0.1 mM Na2EDTA,
0.075% BRIJ58, 50 mM NaCl, 5 mM MgCl2, 50 mg/mL BSA,
and 4% (v/v) glycerol. Reactions were incubated on ice for
0.5 h. Samples were resolved on prerun 6.0% (w/v) native
polyacrylamide gels (39:1 acrylamide:bisacrylamide) at room temperature in TBE buffer (45 mM Tris borate at pH 8.3, 1.25 mM
Na2EDTA), and samples were loaded with the power on. After 2.0 h
of electrophoresis, the gels were dried and complexes were
visualized by PhosphorImaging and quantified using ImageQuant
TL (GE Healthcare). For calculating percent complex formation, the
region on the gel from the slowest migrating complex to the free

v = V m  A=K m ð1 + I=K i Þ + A

(1)

v = v0 =ð1 + I=K i + J=K j + IJ=bK i K j Þ

(2)

Y = min + ð½max  min=½1 + 10ðlog EC50xÞn Þ

(3)
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